New blood pressure drug faces Year-Long safety test
Disease control
Ongoing
This study is testing the long-term safety and effectiveness of a new high blood pressure medication called lorundrostat. It follows over 1,000 people who have already taken the drug in a previous trial for up to a year. The goal is to see if the drug continues to lower blood pre…
Phase: PHASE3 • Sponsor: Mineralys Therapeutics Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC